Self-Prescribed Pharmacological Drugs Used for Covid-19 Prevention and Treatment in the Current Pandemic

Download Article

DOI: 10.21522/TIJPH.2013.10.04.Art017

Authors : Olalekan Fagbola


The practice of using pharmacological drugs not prescribed by qualified medical practitioners is a worrying trend especially in the ongoing Covid-19 pandemic. It is a global issue that has attracted the attention of physicians and various stakeholders in the health care systems in developing and developed countries. Such practice is associated with overdosage, allergic reaction, infection resistant to antibiotic, wrong diagnosis, delay in seeking treatment at health facilities and drug addiction. This study assessed the prevalence of self-prescribed antibiotics, analgesics, vitamins, and minerals by a cross section of burgesses in the Prices Town Regional Corporation (PTRC) in South Trinidad to treat and prevent Covid-19 infection. A descriptive cross-sectional survey in online and paper and pencil questionnaire formats was conducted from February 2022 to April 2022 on 286 self-selected participants from a population of 1000 residents. Data entry and analysis conducted after merging them using Google Charts. Prevalence of Ivermectin was 9.44%, Zithromax 3.15, Steroids 3.5% Panadol 33.6%, Vitamins C 63.3%, Zinc 60.8%, D3 55.2 %, and B Complex 11.9%. Multivariate analysis performed on dependent and independent variables showed that the use of self-prescribed medication was significantly associated with age group 26-35 years (COR 0.15, p0.00129, 95% CI 0.04, 0.51 at significance level of p≤0.05) and marital status of being separated from spouses (COR 2.48, p0.0229, 95% CI 1.02, 6.06, significance level of p≤0.05). More females practiced self-medication compared to males. The researcher recommends health education to curb the practice.

Keywords: Prevalence, Treatment, Self-prescribed antimicrobials, Analgesic, Vitamins, Covid-19, Pandemic, Infection.


[1] Nasir, M., Talha, K. A., Chowdhury, A.S. M., Zahan, T., Rawshan, Perveen, R. A. (2020). Prevalence, Pattern and Impact of Self Medication of Anti-infective Agents During Covid-19 Outbreak in Dhaka City. 10.21203/ file:///C:/Users/Fagbola/Downloads/Prevalence_Pattern_and_Impact_of_Self_Medication_o.pdf].

[2] Sankaranarayanan, R. (2017). Can we classify cross- sectional studies into analytical studies? Retrieved from:          

[3] Malik, M., Tahir, M. J., Jabbar, R., Ahmed, A., & Hussain, R. (2020). Self-medication during Covid-19 pandemic: challenges and opportunities. Drugs & therapy perspectives: for rational drug selection and use, 1–3. Advance online publication.

[4] Ahmad S; Babar M; Essar M; Sinha M and Nadkar A. (2021). Infodemic, Self-medication and stockpiling: a worrying combination. East Mediterr Health J. 2021;27(5):438–440.

[5] Wegbom, A. I, Edet, C. K., Raimi, O., Fagbamigbe, A. F., and Kiri. VA., (2021) Self-Medication Practices and Associated Factors in the Prevention and/or Treatment of Covid-19 Virus: A Population-Based Survey in Nigeria. Front. Public Health.

[6] Quincho-Lopez, A., Benites-Ibarra, C. A., Hilario-Gomez, M. M., Quijano-Escate, R., & Taype-Rondan, A. (2021). Self-medication practices to prevent or manage Covid-19: A systematic review. PloS one, 16(11), e0259317.

[7] Adebisi, Y.A., Jimoh, N.D., and Ogunkola, I. O. (2021). The use of antibiotics in Covid-19 management: a rapid review of national treatment guidelines in 10 African countries. Trop Med Health 49, 51 (2021).

[8] Locquet, Médéa; Diep, Anh Nguyet; Beaudart, Charlotte; Dardenne, Nadia; Brabant, Christian; Bruyère, Olivier; Donneau, A. Françoise. (2021). A systematic review of prediction models to diagnose Covid-19 in adults admitted to healthcare centers. Arch Public Health; 79(1): 105, 2021 Jun 18. DOI: 10.1186/s13690-021-00630-3.

[9]  Popp, M., Stegemann, M., Riemer, M., Metzendorf, M-I., Romero, C. S., Mikolajewska, A., Kranke, P., Meybohm, P., Skoetz, N., and Weibel, S. (2021). Antibiotics for the treatment of Covid-19. Cochrane Database of Systematic Reviews 2021, Issue 10. Art. No.: CD015025. DOI: 10.1002/14651858.CD015025.

[10] Tekeba, A., Ayele, Y., Negash, B., & Gashaw, T. (2021). Extent of and Factors Associated with Self-Medication among Clients Visiting Community Pharmacies in the Era of Covid-19: Does It Relieve the Possible Impact of the Pandemic on the Health-Care System? Risk management and healthcare policy, 14, 4939–4951.

[11] Del-Toro-Rubio, M., Bohórquez-Moreno, C., Díaz-Pérez, A., and Barrios-Puerta, Z. (2020). Factors associated with self-medication in adolescents in the rural area of Cartagena, Colombia. Arch Med (Manizales) 2020; 20(2):356-363.

[12] Abdelwahed RNK, Jassem M, Alyousbashi A. Self-Medication Practices, Prevalence, and Associated Factors among Syrian Adult Patients: A Cross-Sectional Study. J Environ Public Health. 2022 Jun 28; 2022:9274610. doi: 10.1155/2022/9274610. PMID: 35800339; PMCID: PMC9256391.

[13] Hughes, C. M., McElnay, J. C., & Fleming, G. F. (2001). Benefits and risks of self-medication. Drug safety, 24(14), 1027–1037.

[14] WHO (2000). World Health Organization Guidelines for the Regu latory Assessment of Medicinal Products for use in Self-Medication.

[15] Topinková, E., Baeyens, J.P., Michel, JP. et al. (2012). Evidence-Based Strategies for the Optimization of Pharmacotherapy in Older People. Drugs Aging 29, 477–494 (2012).

[16] Montastruc, J. L., Bagheri, H., Geraud, T., & Lapeyre-Mestre, M. (1997). Pharmacovigilance de l’automédication [Pharmacovigilance of self-medication]. Therapie, 52(2), 105–110.

[17] Fair, R. J., & Tor, Y. (2014). Antibiotics and bacterial resistance in the 21st century. Perspectives in medicinal chemistry, 6, 25–64.

[18]Banić Tomišić, Z. (2011). The Story of Azithromycin. Kemija u industriji/Journal of Chemists and Chemical Engineers. 60. 603-617.

[19] Hauk L. (2014). AAP releases guideline on diagnosis and management of acute bacterial sinusitis in children one to 18 years of age. American family physician, 89(8), 676–681.

[20] Oldenburg CE, Pinsky BA, Brogdon J, et al. Effect of Oral Azithromycin vs Placebo on Covid-19 Symptoms in Outpatients With SARS-CoV-2 Infection: A Randomized Clinical Trial. JAMA. 2021;326(6):490–498. doi:10.1001/jama.2021.11517.

[21] Dorobisz, K., Dorobisz, T., Janczak, D., & Zatoński, T. (2021). Doxycycline in the Coronavirus Disease 2019 Therapy. Therapeutics and clinical risk management, 17, 1023–1026.

[22] Chivese, T., Omran A.H., Musa, G. H., Al-Wattary, N., Badran, S., Soliman, N., Ahmed T.M., Matizanadzo, J., Mohamed M. M., Thalib, E. L., and Suhail A.R. (2021). Efficacy of chloroquine and hydroxychloroquine in treating Covid-19 infection: A meta-review of systematic reviews and an updated meta-analysis, Travel Medicine and Infectious Disease, Volume 43, 2021, 02135, ISSN 1477-8939,

[23] Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., Xiao, Y., … Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England), 395(10223), 497–506.

[24] Gao, J., Zheng, P., Jia, Y., Chen, H., Mao, Y., Chen, S., Wang, Y., Fu, H., & Dai, J. (2020). Mental health problems and social media exposure during Covid-19 outbreak. PloS one, 15(4), e0231924.

[25] Singh, S., Roy, D., Sinha, K., Parveen, S., Sharma, G., & Joshi, G. (2020). Impact of Covid-19 and lockdown on mental health of children and adolescents: A narrative review with recommendations. Psychiatry research, 293, 113429.

[26] Caly. L., Druce J.D., Catton, M.G., Jans, D.A., Wagstaff, K.M. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Research, Volume 178, 2020,104787, ISSN 0166 3542, (

[27] DiNicolantonio, J. J., Barroso-Arranda, J., McCarty, M. (2020). Ivermectin may be a clinically useful anti-inflammatory agent for late-stage Covid-19. Open Heart 2020;7: e001350. doi:10.1136/ openhrt-2020-001350.

[28] Babalola, O. E., Bode, C. O., Ajayi, A. A., Alakaloko, F. M., Akase, I. E., Otrofanowei, E., Adeyemo, A. O., and Omilabu, S. (2021) change to 2022. Ivermectin shows clinical benefits in mild to moderate covid-19: a randomized controlled double blind dose response study in Lagos. medRxiv 2021.01.05.21249131; doi:

[29] Baracaldo-Santamaría, D., Pabón-Londoño, S., & Rojas-Rodriguez, L. C. (2022). Drug safety of frequently used drugs and substances for self-medication in Covid-19. Therapeutic advances in drug safety, 13, 20420986221094141.

[30] Moore, N. Bosco-Levy, P., Thurin, N., Blin, P., & Droz-Perroteau, C. (2021). NSAIDs and Covid-19: A Systematic Review and Meta-analysis. Drug safety, 44(9), 929–938.

[31] Reese, J.T., Coleman, B., Chan, L. (2022). NSAID use and clinical outcomes in Covid-19 patients: a 38-center retrospective cohort study. Virol J 19, 84 (2022).

[32] Zhou, Q., Zhao, S., Gan, L., Wang, Z., Peng, S., Li, Q., Liu, H., Liu, X., Wang, Z., Shi, Q., Estill, J., Luo, Z., Wang, X., Liu, E., & Chen, Y. (2022). Use of non-steroidal anti-inflammatory drugs and adverse outcomes during the Covid-19 pandemic: A systematic review and meta-analysis. EClinicalMedicine, 46, 101373.

[33] Kow, C. S., & Hasan, S. S. (2021). The risk of mortality in patients with Covid-19 with pre-diagnosis use of NSAIDs: a meta-analysis. Inflammopharmacology, 29(3), 641–644.

[34] Abu Esba, L.C., Alqahtani, R.A., Thomas, A. et al. (2021)/ Ibuprofen and NSAID Use in Covid-19 Infected Patients Is Not Associated with Worse Outcomes: A Prospective Cohort Study. Infect Dis Ther 10, 253–268 (2021).

[35] Manjani, L., Desai, N., Kohli, A., Arya, R., Woods, C., and Desale, S. (2021). Effects of acetaminophen on outcomes in patients hospitalized with Covid-10. Presented at: CHEST 2021; October 17-20, 2021; Orlando, FL/Virtual. Abstract A1072.

[36] Sestili P, Fimognari, C. (2020). Paracetamol‐Induced Glutathione Consumption: Is There a Link with Severe Covid‐19 Illness? Front Pharmacol. 2020;11: 579944. 10.3389/fphar.2020.579944

[37] Pandolfi, S., Simonetti, V., Ricevuti, G., & Chirumbolo, S. (2021). Paracetamol in the home treatment of early Covid-19 symptoms: A possible foe rather than a friend for elderly patients? Journal of medical virology, 93(10), 5704–5706.

[38] Kelleni M. T. (2022). NSAIDs and Kelleni’s protocol as potential early Covid-19 treatment game changer: could it be the final countdown? Inflammopharmacology, 30(1), 343–348.

[39] Wijaya, I., Andhika, R., Huang, I., Purwiga, A., & Budiman, K. Y. (2021). The effects of aspirin on the outcome of Covid-19: A systematic review and meta-analysis. Clinical epidemiology and global health, 12, 100883.

[40] Voruganti, D., Bassareo, P. P. and Calcaterra, G. (2022). Does aspirin save lives in patients with Covid-19? Heart 2022; 108:88-89.

[41] Mosleh, G., Badr, P., Zaeri, M., & Mohagheghzadeh, A. (2021). Potentials of Antitussive Traditional Persian Functional Foods for Covid-19 Therapy. Frontiers in pharmacology, 12, 624006.

[42] Zhang, D. H., Zhang, X., Peng, B., Deng, S. Q., Wang, Y. F., Yang, L., Zhang, K. Z., Ling, C. Q., & Wu, K. L. (2020). Network pharmacology suggests biochemical rationale for treating Covid-19 symptoms with a Traditional Chinese Medicine. Communications biology, 3(1), 466.

[43] Esam Z. (2020). Protective potential of expectorants against Covid-19. Medical hypotheses, 142, 109844.

[44] Wang, Z., Yang, B., Li, Q., Wen, L., & Zhang, R. (2020). Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 71(15), 769–777.

[45] Lansbury, L., Lim, B., Baskaran, V., & Lim, W. S. (2020). Co-infections in people with Covid-19: a systematic review and meta-analysis. The Journal of infection, 81(2), 266–275.

[46] Pahwa R, Goyal A, and Jialal I. (2021). Chronic Inflammation. [Updated 2021 Sep 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from:

[47] Bao, B., Prasad, A. S., Beck, F. W., Fitzgerald, J. T., Snell, D., Bao, G. W., Singh, T., & Cardozo, L. J. (2010). Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent. The American journal of clinical nutrition, 91(6), 1634–1641.

[48] Jurowski, K., Szewczyk, B., Nowak, G., & Piekoszewski, W. (2014). Biological consequences of zinc deficiency in the pathomechanisms of selected diseases. Journal of biological inorganic chemistry: JBIC: a publication of the Society of Biological Inorganic Chemistry, 19(7), 1069–1079.

[49] Shah, D., Sachdev, H. S., Gera, T., De-Regil, L. M., & Peña-Rosas, J. P. (2016). Fortification of staple foods with zinc for improving zinc status and other health outcomes in the general population. The Cochrane database of systematic reviews, 2016(6), CD010697.

[50] Tan, B., Chew, N., Lee, G., Jing, M., Goh, Y., Yeo, L., Zhang, K., Chin, H. K., Ahmad, A., Khan, F. A., Shanmugam, G. N., Chan, B., Sunny, S., Chandra, B., Ong, J., Paliwal, P. R., Wong, L., Sagayanathan, R., Chen, J. T., Ng, A., Sharma, V. K. (2020). Psychological Impact of the Covid-19 Pandemic on Health Care Workers in Singapore. Annals of internal medicine, 173(4), 317–320.

[51] Ragan, I., Hartson, L., Pidcoke, H., Bowen, R., & Raymond P. (2020). Pathogen reduction of SARS-CoV-2 virus in plasma and whole blood using riboflavin and UV light. doi:

[52] Mikkelsen, K., Stojanovska, L., Prakash, M., & Apostolopoulos, V. (2017). The effects of vitamin B on the immune/cytokine network and their involvement in depression. Maturitas, 96, 58–71.

[53] Shakoor, H., Feehan, J., Al Dhaheri, A., Ali, H., Platat, C., Ismail, L., Apostolopoulos, V., Stojanovska, L. (2020). Immune-boosting role of vitamins D, C, E, zinc, selenium, and omega-3 fatty acids: Could they help against Covid-19? Maturitas. 143. 10.1016/j.maturitas.2020.08.003.

[54] Carr, A. C., & Rowe, S. (2020). The Emerging Role of Vitamin C in the Prevention and Treatment of Covid-19. Nutrients, 12(11), 3286.

[55] Chambial, S., Dwivedi, S., Shukla, K. K., John, P. J., & Sharma, P. (2013). Vitamin C in disease prevention and cure: an overview. Indian journal of clinical biochemistry: IJCB, 28(4), 314–328.

[56] Schlueter, A. K., & Johnston, C. S. (2011). Vitamin C: Overview and Update. Journal of Evidence-Based Complementary & Alternative Medicine, 49–57.

[57] Holford, P., Carr, A. C., Jovic, T. H., Ali, S. R., Whitaker, I. S., Marik, P. E., & Smith, A. D. (2020). Vitamin C-An Adjunctive Therapy for Respiratory Infection, Sepsis and Covid-19. Nutrients, 12(12), 3760.

[58] Pisoschi, A.M., et al. (2021) Oxidative Stress Mitigation by Antioxidants—An Overview on Their Chemistry and Influences on Health Status. European Journal of Medicinal Chemistry, 209, Article ID: 112891.

[59] Science, M., Maguire, J. L., Russell, M. L., Smieja, M., Walter, S. D., & Loeb, M. (2013). Low serum 25-hydroxyvitamin D level and risk of upper respiratory tract infection in children and adolescents. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 57(3), 392–397.

[60] Aglipay, M., Birken, C. S., Parkin, P. C., Loeb, M. B., Thorpe, K., Chen, Y., Laupacis, A., Mamdani, M., Macarthur, C., Hoch, J. S., Mazzulli, T., Maguire, J. L., & TARGet Kids! Collaboration (2017). Effect of High-Dose vs Standard-Dose Wintertime Vitamin D Supplementation on Viral Upper Respiratory Tract Infections in Young Healthy Children. JAMA, 318(3), 245–254.

[61] Hafez, W., Saleh, H., Al Baha, Z., Tariq, M., Hamdan, S., & Ahmed, S. (2022). Antiviral Used among Non-Severe Covid-19 Cases in Relation to Time till Viral Clearance: A Retrospective Cohort Study. Antibiotics, 11(4), 498. MDPI AG. Retrieved from

[62] Murai, I. H., Fernandes, A. L., Sales, L. P. et al. (2020). Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients with Moderate to Severe Covid-19: A Randomized Clinical Trial. JAMA. 2021;325(11):1053–1060. doi:10.1001/jama.2020.26848.

[63] Olayemi J, Olayinka B, Musa I. (2010). Evaluation of Antibiotic Self-Medication Pattern Amongst Undergraduate Students of Ahmadu Bello University (Main Campus), Zaria. Journal Applied Sciences and Engineering Technology, 2(1): 35-38.

[64] Elayeh, E., Akour, A., &Haddadin, R. N. (2021). Prevalence and predictors of self-medication drugs to prevent or treat Covid-19: Experience from a Middle Eastern country. International journal of clinical practice, 75(11), e14860.

[65] Amaha. M. H., Alemu, B.M, and Atomsa, G. E. (2019) Self-medication practice and associated factors among adult community members of Jigjiga town, Eastern Ethiopia. PLoS ONE 14(6): e0218772.

[66] Alshammari F, Alobaida A, Alshammari A, Alharbi A, Alrashidi A, Almansour A, Alremal A and Khan KU (2021) University Students’ Self-Medication Practices and Pharmacists’ Role: A Cross-Sectional Survey in Hail, Saudi Arabia. Front. Public Health 9:779107. doi: 10.3389/fpubh.2021.779107.

[67] Zeru N, Fetene D, Geberu DM, Melesse AW, Atnafu A. Self-Medication (2020): Practice and Associated Factors Among University of Gondar College of Medicine and Health Sciences Students: A Cross-Sectional Study. Patient Prefer Adherence. 2020; 14:1779-1790

[68] Makowska, M., Boguszewski, R., Nowakowski, M., & Podkowińska, M. (2020). Self-Medication-Related Behaviors and Poland’s Covid-19 Lockdown. International Journal of Environmental Research and Public Health, 17(22), 8344. MDPI AG. Retrieved from

[69] Shaamekhi, H. R., Asghari Jafarabadi, M., & Alizadeh, M. (2019). Demographic determinants of self-medication in the population covered by health centers in Tabriz. Health promotion perspectives, 9(3), 181–190.

[70] Demissie, F., Ereso, K., & Paulos, G. (2022). Self-Medication Practice with Antibiotics and Its Associated Factors Among Community of Bule-Hora Town, Southwest Ethiopia. Drug, healthcare, and patient safety, 14, 9–18.

[71] Bello, I, B., Akinnawo, E, O., Akpunne, B, O., Mopa-Egbunu, A. (2022). Knowledge of Covid-19 and preventive measures on self-medication practices among Nigerian undergraduates, Cogent Arts & Humanities, 9:1, 2049480, DOI: 10.1080/23311983.2022.2049480.